Aktuellt
SENASTE
We reiterate our valuation range of SEK 61-81. Bactiguard transformed during 2023, from primarily being a medical device production company to helping medtech companies launch devices with Bactiguard’s coating technology. At sufficient scale, this business model is highly profitable meaning the success hinges on Bactiguard’s ability to deliver on current partnerships (BD is a good example) and the amount of potential new deals.
LÄS MER
